We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-16.7%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$5.13B
(-23%)
Cap. Flow
-$794M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
156
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$108M |
| 2 |
Visa
V
|
+$102M |
| 3 |
Mercado Libre
MELI
|
+$73M |
| 4 |
Enphase Energy
ENPH
|
+$58.6M |
| 5 |
Snowflake
SNOW
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$147M |
| 2 |
Y
Alleghany Corp
Y
|
+$137M |
| 3 |
Applied Materials
AMAT
|
+$116M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Industrials | 25.1% |
| 3 | Healthcare | 17.44% |
| 4 | Financials | 14.96% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Samsara
IOT
$24.3B
| $420K | ﹤0.01% |
37,569
| – | – |
|
327
Allegro MicroSystems
ALGM
$6.29B
| $414K | ﹤0.01% |
20,033
| – | – |
|
328
Biomea Fusion
BMEA
$122M
| $397K | ﹤0.01% |
+33,155
| New | +$194K |
|
329
Navitas Semiconductor
NVTS
$2.82B
| $389K | ﹤0.01% |
100,721
-49,497
| -33% | -$342K |
|
330
Health Catalyst
HCAT
$132M
| $386K | ﹤0.01% |
26,640
+11,885
| +81% | +$203K |
|
|
BLDP
331
Ballard Power Systems
BLDP
$642M
| $372K | ﹤0.01% |
51,251
-3,495
| -6% | -$28K |
|
332
Lumentum
LITE
$76.4B
| $364K | ﹤0.01% |
4,586
-34,275
| -88% | -$2.93M |
|
333
Coherent
COHR
$54.3B
| $361K | ﹤0.01% |
7,076
-1,235
| -15% | -$75.3K |
|
334
Silicon Laboratories
SLAB
$7.32B
| $341K | ﹤0.01% |
2,432
-715
| -23% | -$100K |
|
335
Acuity Brands
AYI
$9.08B
| $335K | ﹤0.01% |
2,175
-566
| -21% | -$96K |
|
336
Lyft
LYFT
$5.92B
| $328K | ﹤0.01% |
24,714
| – | – |
|
337
Sunrun
RUN
$2.02B
| $326K | ﹤0.01% |
13,965
-2,243
| -14% | -$53.9K |
|
338
IPG Photonics
IPGP
$3.21B
| $325K | ﹤0.01% |
3,448
-726
| -17% | -$71.8K |
|
339
Establishment Labs
ESTA
$2.11B
| $320K | ﹤0.01% |
5,891
| – | – |
|
340
HealthEquity
HQY
$7.96B
| $316K | ﹤0.01% |
5,145
-1,500
| -23% | -$96.1K |
|
341
Joby Aviation
JOBY
$6.14B
| $313K | ﹤0.01% |
63,776
| – | – |
|
|
APLS
342
DELISTED
Apellis Pharmaceuticals
APLS
| $312K | ﹤0.01% |
+6,900
| New | +$315K |
|
343
Ormat Technologies
ORA
$5.66B
| $292K | ﹤0.01% |
+3,726
| New | +$294K |
|
344
EVgo
EVGO
$201M
| $274K | ﹤0.01% |
45,537
-3,112
| -6% | -$29.6K |
|
|
NATI
345
DELISTED
National Instruments Corp
NATI
| $272K | ﹤0.01% |
8,718
-1,679
| -16% | -$59.5K |
|
346
Semtech
SMTC
$14.3B
| $232K | ﹤0.01% |
4,219
-827
| -16% | -$49.9K |
|
347
Enovix
ENVX
$650M
| $230K | ﹤0.01% |
29,441
-1,085
| -4% | -$10.2K |
|
|
LAZR
348
DELISTED
Luminar Technologies
LAZR
| $226K | ﹤0.01% |
2,545
| – | – |
|
|
JKS
349
JinkoSolar
JKS
$571M
| $225K | ﹤0.01% |
+3,250
| New | +$182K |
|
350
Dana Inc
DAN
$3.28B
| $217K | ﹤0.01% |
15,413
+96
| +0.6% | +$1.49K |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, Polar Capital Holdings held 494 positions worth $17B, down 23% from $22.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Polar Capital Holdings withdrew a net $794M in Q2 2022, closing 61 positions and reducing 156 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Polar Capital Holdings opened a new position in Sanofi worth $36.3M.
- Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3M.
- Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
- Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
- Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147M.
- Polar Capital Holdings's ten largest holdings make up 43% of its $17B portfolio in Q2 2022.
- Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
- Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17B.
Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.